Response to Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients' Clinical Management".

Viola, David; Poma, Anello Marcello; Elisei, Rossella; Basolo, Fulvio

Viola, David; Poma, Anello Marcello; Elisei, Rossella; Basolo, Fulvio.

Afiliação

Viola D; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Poma AM; Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Italy.
Elisei R; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Basolo F; Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Italy.

J Clin Endocrinol Metab ; 107(6): e2653-e2654, 2022 05 17.

Article em En | MEDLINE | ID: mdl-35100613

Assuntos

Carcinoma Papilar; Neoplasias da Glândula Tireoide; Humanos; Câncer Papilífero da Tireoide

Palavras-chave

papillary thyroid carcinoma; prognosis; recurrence-free survival; tall cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Papilar Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google